Biohaven (BHVN) is down -17.0%, or -$3.35 to $16.31.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHVN:
- Biohaven Ltd.’s Resilience and Strategic Growth Potential Amidst Regulatory Challenges
- Biohaven’s Troriluzole PDUFA Date Extended by FDA
- Biohaven Ltd. Receives Buy Rating Amid Promising FDA Progress and Strong Financial Position
- Closing Bell Movers: Foot Locker up nearly 70% on Dick’s buyout
- FDA extends PDUFA for Biohaven’s Troriluzole new drug application